A multinational active safety surveillance study of crizotinib in Europe and the United States

First published 02/12/2014

Last updated 02/07/2024

EU PAS number:

EUPAS8097

Study

Finalised

Documents

Study protocol

Initial protocol

A8081038 Final Crizotinib Protocol 02 April 2013

English (1.63 MB - PDF)View document

Updated protocol

A8081038 Final Protocol Amendment 2, 19 February 2015 register

First published: 22/02/2024

English (486.25 KB - PDF)View document

Study results

Study report

A8081038 NI Study Report

English (3.23 MB - PDF)View document

Crizotinib A8081038 Second Interim Report Synopsis_21 Sept 2016

English (151.16 KB - PDF)View document

Other information

Study, other information

Crizotinib A8081038 Second Interim Report Synopsis_21 Sept 2016.pdf

English (151.16 KB - PDF)View document

ENCePP Seal

ENCePP Seal documents

Secondary tabs